(1R,2R)-N-([S]-1-4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-ylpropan-2-yl)-2-phenylcyclopropanecarboxamide
≥95%
- Product Code: 106696
CAS:
1246303-14-9
| Molecular Weight: | 497.43 g./mol | Molecular Formula: | C₂₅H₂₉BrN₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily utilized in the field of medicinal research, particularly in the development of therapeutic agents targeting specific protein interactions. Its structure suggests potential activity as a modulator or inhibitor in biochemical pathways, making it a candidate for the treatment of diseases where such pathways are dysregulated. Researchers are exploring its efficacy in conditions like cancer, neurological disorders, and inflammatory diseases. Its unique configuration allows it to bind selectively to certain receptors or enzymes, potentially reducing side effects and improving therapeutic outcomes. Ongoing studies focus on optimizing its pharmacokinetics and pharmacodynamics to enhance its clinical applicability.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿14,301.00 |
+
-
|
| 0.005 | 10-20 days | ฿40,500.00 |
+
-
|
(1R,2R)-N-([S]-1-4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-ylpropan-2-yl)-2-phenylcyclopropanecarboxamide
This compound is primarily utilized in the field of medicinal research, particularly in the development of therapeutic agents targeting specific protein interactions. Its structure suggests potential activity as a modulator or inhibitor in biochemical pathways, making it a candidate for the treatment of diseases where such pathways are dysregulated. Researchers are exploring its efficacy in conditions like cancer, neurological disorders, and inflammatory diseases. Its unique configuration allows it to bind selectively to certain receptors or enzymes, potentially reducing side effects and improving therapeutic outcomes. Ongoing studies focus on optimizing its pharmacokinetics and pharmacodynamics to enhance its clinical applicability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :